What is the ticker symbol for Gamida Cell?

Gamida Cell trades under the ticker GMDA on NASDAQ.

What sector does Gamida Cell operate in?

Gamida Cell is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GMDA in a portfolio?

PortView shows GMDA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Gamida Cell (GMDA) Stock Analysis

NASDAQHealthcareBiotechnology

$0.03+0.00%

1-year price historyRange $0.01 – $2.37

52-week range$0.03

$0.03$0.04

What Gamida Cell does

Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Beyond these, Gamida Cell is actively advancing a broader natural killer (NK) cell pipeline, which includes GDA-301, GDA-401, GDA-501, and GDA-601, with the ambition of treating both hematologic cancers and solid tumors. Founded in 1998, the company maintains its corporate headquarters in Jerusalem, Israel.

Key metrics

Market cap

$4.34M

P/E (TTM)

-0.04

EPS (TTM)

$-0.82

Beta

1.03

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$0.03

200-day avg

$0.03

52-week high

$0.04

52-week low

$0.03

CEO

Abigail L. Jenkins

ETFs linked to GMDA

Broad-market and Healthcare sector ETFs an investor holding Gamida Cell is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GMDA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GMDA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Gamida Cell?: Gamida Cell trades under the ticker GMDA on NASDAQ.
Which exchange is GMDA listed on?: GMDA is listed on NASDAQ.
What sector does Gamida Cell operate in?: Gamida Cell is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GMDA in a portfolio?: PortView shows GMDA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.